Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Vacunek

Vacunek
2006 FOUNDED
PRIVATE STATUS
Seed LATEST DEAL TYPE
$277K LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of biotechnology products intended to focus on the application of new biotechnological tools for animal health. The company's products are used as a development of biological immunity against animal mycobacteriosis in livestock and wild species, enabling farmers to detect and cure various bacterial animal diseases.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • Parque Científico y Tecnológico de Bizkaia. Ed. 612 1º planta
  • 1st floor
  • 48160 Derio
  • Spain

+34 946 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Vacunek’s full profile, request a free trial.

Vacunek Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 01-Jan-2007 $277K 00000 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Vacunek Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Bizkaia Seed Capital Venture Capital Minority 000 0000 000000 0

Vacunek Executive Team (1)

Name Title Board
Seat
Contact
Info
Beatriz Ocio Director, Operations

Vacunek Board Members (1)

Name Representing Role Since Contact
Info
Isibene Sánchez Vacunek Board Member 000 0000